Back to results

CompletedPhase 2

Evaluation of Patiromer in Heart Failure Patients

NCT00868439

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Investigator Site 029

Miami, Florida, United States

+32 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2009-04
Enrollment: 120 participants
Sponsor: Relypsa, Inc.
Purpose: prevention

Locations (33)

Investigator Site 029Miami, Florida, United States
Investigator Site 031Port Charlotte, Florida, United States
Investigator Site 009Peoria, Illinois, United States
Investigator Site 018Minneapolis, Minnesota, United States
Investigator Site 020Buffalo, New York, United States
Investigator Site 005Northport, New York, United States
Investigator Site 022Columbus, Ohio, United States
Investigator Site 001Dallas, Texas, United States
Investigator Site 019Salt Lake City, Utah, United States
Investigator Site 102Brno, Czechia
Investigator Site 104Prague, Czechia
Investigator Site 103Prague, Czechia
Investigator Site 605Tbilisi, Georgia
Investigator Site 602Tbilisi, Georgia
Investigator Site 604Tbilisi, Georgia
Investigator Site 603Tbilisi, Georgia
Investigator Site 201Göttingen, Germany
Investigator Site 202Heidelberg, Germany
Investigator Site 305Warsaw, Poland
Investigator Site 409Barnaul, Russia
Investigator Site 407Kemerovo, Russia
Investigator Site 406Moscow, Russia
Investigator Site 402Moscow, Russia
Investigator Site 403Moscow, Russia
Investigator Site 404Saint Petersburg, Russia
Investigator Site 412Saint Petersburg, Russia
Investigator Site 405Saint Petersburg, Russia
Investigator Site 507Dnipropetrovsk, Ukraine
Investigator Site 502Kharkiv, Ukraine
Investigator Site 509Kharkiv, Ukraine
Investigator Site 504Kiev, Ukraine
Investigator Site 506Kiev, Ukraine
Investigator Site 501Kiev, Ukraine

Evaluation of Patiromer in Heart Failure Patients — TrialFind